Corient Private Wealth’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Corient Private Wealth's MDT Position: Q1 2026 in Review
Corient Private Wealth reduced its Medtronic (MDT) stake by 59% in Q1 2026, selling an estimated $76M and leaving 560,236 shares worth $48.2M. The position accounts for 0.07% of the portfolio, ranked #244.
Corient Private Wealth first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $113M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Corient Private Wealth held 560,236 shares of Medtronic worth $48.2M as of Q1 2026.
- Corient Private Wealth sold 793,646 Medtronic shares in Q1 2026, an estimated $76M.
- Medtronic made up 0.07% of Corient Private Wealth's portfolio in Q1 2026, its #244 holding.
- Corient Private Wealth first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
- Corient Private Wealth's Medtronic position peaked at $113M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.